AI and the Business of Healthcare, Statistics and Benchmarks

Administrative Cost Burden

The cost of running hospitals in the United States is heavily administrative. These figures quantify work that does not involve patient care, and they define the opportunity AI can absorb.

The 25 percent figure is hospital specific. The 31 percent figure captures administration across the entire U.S. healthcare system, including insurance overhead. Either way, the cost is structural. It does not appear on a single budget line. It is distributed across every department and absorbed by existing staff.

AI Adoption in Health Systems

Adoption is now broad but uneven. Most hospitals run AI somewhere, but far fewer have embedded it deeply into core workflows.

The gap between broad adoption (80 percent) and deep clinical integration (under 20 percent) is the central structural fact. Organizations are running AI somewhere. Far fewer have it embedded in the workflows where the financial return lives.

What Health Systems Want From AI

A 2025 study published in JAMIA surveyed 43 U.S. health systems on their top goals for deploying AI. The results cut against the assumption that margin improvement is the primary driver.

Source. Poon et al., JAMIA 2025. Survey of 43 U.S. health systems. Caregiver burden and workflow efficiency dominate. Margin improvement ranks fourth at 12 percent. The financial case for AI is real, but health systems are prioritizing the human cost of broken workflows first.

Revenue Cycle and Denials

The revenue cycle is where AI delivers the most measurable financial return. Denial prevention, not denial recovery, is where the savings concentrate.

Every denied claim that is prevented upstream saves the rework cost, the staff hours, and the revenue cycle lag. AI claim scrubbing and eligibility verification move the intervention from after denial to before submission.

Prior Authorization

Prior authorization is one of the most widely cited administrative burdens in U.S. healthcare. The hours are measurable, and AI can absorb a significant share.

AI absorbs prior authorization work by extracting clinical documentation and submitting requests to payer portals automatically. The 13 hours per physician per week is the baseline. The opportunity is measurable in both hours returned and care delays prevented.

Documentation and Workflow

AI scribes, ambient documentation, and EHR summarization have produced the clearest, most repeatable productivity gains in clinical operations.

Financial Impact and ROI

Short-payback ROI is now consistently reported across vendors and health systems. The financial case has moved from theoretical to measurable.

The 3.2 to 1 ROI and 12 to 18 month payback figures are industry averages. Individual deployments vary based on workflow mapping, baseline rigor, and change management. The 2x minimum is the practical bar for scaling a deployment after its 90-day proof window.

FDA and Regulatory

The FDA AI/ML device list is the single best leading indicator of clinical-grade AI maturity. It is public, dated, and taxonomized.

Radiology dominates the regulatory landscape. The vast majority of FDA-cleared devices are narrow, task-specific models trained on labeled medical imaging data. Generative and foundation-model AI represents a limited but growing share.

Clinical Diagnostic Accuracy

Narrow AI models matched against bounded tasks now reach or exceed specialist performance. The gap appears when models are asked to handle open-ended diagnosis on unfiltered presentations.

Market Size and Growth

Healthcare is one of the largest verticals for AI spending. Every credible synthesis projects a tripling to quintupling of market size between 2025 and the early 2030s.

Patient Engagement

Consumer-side adoption of AI in healthcare has run faster than the institutional side. Patients are already using general-purpose AI tools to interpret their own care.

How to Use These Benchmarks

These figures serve three purposes for health system leaders evaluating AI.